Connect Share Price

Connect Share Price

NASDAQ: CNTB | Micro Cap | Healthcare
$0.66
+$0.09 (15.61%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Connect Stock Performance

Open
$0.57
Prev. Close
$0.57
Circuit Range
N/A
Day Range
$0.57 - $0.64
Year Range
$0.55 - $3.74
Volume
15,213
Average Traded
$0.62

Connect Share Price Today

As of 19 November 2026, Connect Biopharma Holdings Limited's share price is $0.66. The stock opened at $0.57, compared to its previous close of $0.57. During today's trading session, Connect Biopharma Holdings Limited's share price traded between $0.57 and $0.64, with an average price of $0.60. Over the past 52 weeks, the stock has recorded a high of $3.74 and a low of $0.55. In terms of performance, Connect Biopharma Holdings Limited's share price has declined by 73.46% over the last six months and is down 76.15% on a year-on-year basis.

Connect Share Price Chart

Line chart of the Connect price trend over the selected period. The price rose overall, ranging from 0.57 to 0.66, ending at 0.66.
$0.57$0.64
L
Show Current Price
H

Connect Stock Fundamentals & Key Indicators

Market Cap
$36.64M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.10
Revenue (TTM)
$60.00M
Return On Equity (TTM)
-257.93%
Profit Margin
-92466.67%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-1.05%

Connect Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.02$0.00$0.17$2.77
Net Profit-$17.10-$15.50-$19.40-$17.28
Net Profit Margin-85500.00%N/A-11411.76%-623.83%
Income ChangeN/A9.36%-25.16%10.93%

Connect Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$26.03$0.06
Net Profit-$118.09-$62.11-$15.63-$55.48
Net Profit MarginN/AN/A-60.05%-92466.67%
Income ChangeN/A47.40%74.83%-254.96%

Connect Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets5.154.324.8218.23
Current Assets50.9396.96122.55155.78
Total Assets56.08101.28127.38174.01
Non Current Liabilities0.480.660.590.9
Current Liabilities13.618.4625.2915.62
Total Liabilities14.19.1225.8816.52
Shareholders' Equity41.9892.17101.5157.49

Connect Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-51.21-23.61-47.74-101.52
Investing9.82-3.4574.98-86.24
Financing1.090.230.05-0.09

About Connect

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Connect Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.80
$0.62
-22.29%
Oct 2026
$1.11
$0.79
-27.49%
Sep 2026
$2.19
$1.09
-51.97%
Aug 2026
$2.06
$2.28
+12.87%
Jul 2026
$2.39
$2.02
-14.95%
Jun 2026
$2.49
$2.38
-4.23%
May 2026
$2.46
$2.48
+1.22%
Apr 2026
$2.69
$2.45
-5.77%
Mar 2026
$2.50
$2.60
+4.00%
Feb 2026
$2.44
$2.50
+2.67%
Jan 2026
$2.68
$2.44
-13.04%
Dec 2025
$2.77
$2.80
+1.45%

Connect Share Price FAQs